Department of Biological Sciences, Tokyo Metropolitan University, 1-1 Minami-Osawa, Hachioji, Tokyo, 192-0397, Japan.
Nano Medical Engineering Laboratory, RIKEN Cluster for Pioneering Research, 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan.
Anal Sci. 2021 May 10;37(5):707-712. doi: 10.2116/analsci.20SCP20. Epub 2021 Jan 22.
In vitro selection has been widely used to generate molecular-recognition elements in analytical sciences. Although reconstituted types of in vitro transcription and translation (IVTT) system, such as PURE system, are nowadays widely used for ribosome display and mRNA/cDNA display, use of E. coli extract is often avoided, presumably because it contains unfavorable contaminants, such as ribonuclease. Nevertheless, the initial speed of protein translation in E. coli extract is markedly faster than that of PURE system. We thus hypothesized that E. coli extract is more appropriate for instant translation in ribosome display than PURE system. Here, we first revisit the potency of E. coli extract for ribosome display by shortening the translation time, and then applied the optimized condition for selecting peptide aptamers for ovalbumin (OVA). The OVA-binding peptides selected using E. coli extract exhibited specific binding to OVA, even in the presence of 50% serum. We conclude that instant translation in ribosome display using E. coli extract has the potential to generate easy-to-use and economical molecular-recognition elements in analytical sciences.
体外选择已广泛用于分析科学中的分子识别元件的生成。尽管现在广泛使用 PURE 系统等重组类型的体外转录和翻译 (IVTT) 系统进行核糖体展示和 mRNA/cDNA 展示,但通常避免使用大肠杆菌提取物,大概是因为它含有不利的污染物,如核糖核酸酶。然而,大肠杆菌提取物中蛋白质翻译的初始速度明显快于 PURE 系统。因此,我们假设大肠杆菌提取物在核糖体展示中比 PURE 系统更适合即时翻译。在这里,我们首先通过缩短翻译时间重新审视大肠杆菌提取物在核糖体展示中的效力,然后将优化条件应用于选择卵清蛋白 (OVA) 的肽适体。使用大肠杆菌提取物选择的 OVA 结合肽即使在存在 50%血清的情况下也能特异性结合 OVA。我们得出结论,使用大肠杆菌提取物的核糖体展示中的即时翻译有可能在分析科学中生成易于使用和经济的分子识别元件。